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Abstract: Introduction: Worldwide, health systems are improving access to empirically supported 
psychological therapies for anxiety and depression. Evaluations of this effort are limited by the cross 
sectional nature of studies, short implementation periods, poor data completeness rates and lack of 
clinically significant and reliable change metrics. 
 
Objective: Assess the impact of implementing stepped care empirically supported psychological 
therapies by measuring the prospective outcomes of patients referred over a two year period to one 
Improving Access to Psychological Therapies service in the UK. 
 
Method: We collected demographic, therapeutic and outcome data on depression (PHQ-9) and anxiety 
(GAD-7) from 7,859 consecutive patients for 24 months between1st July 2006 and 31st August 2008, 
following up these patients for a further one year.  
 
Results: 4,183 patients (53%) received two or more treatment sessions. Uncontrolled effect size for 
depression was 1.07 (95% CI: 0.88 to 1.29) and for anxiety was 1.04 (0.88 to 1.23). 55.4% of treated 
patients met reliable improvement or reliable and clinically significant change criteria for depression, 
54.7% for anxiety. Patients received a mean of 5.5 sessions over 3.5 hours, mainly low-intensity CBT 
and phone based case management. Attrition was high with 47% of referrals either not attending for 
an assessment or receiving an assessment only. 
 
Conclusions: Recovery rates for patients receiving stepped care empirically supported treatments for 
anxiety and depression in routine practice are 40 to 46%. Only half of all patients referred go on to 
receive treatment. Further work is needed to improve routine engagement of patients with anxiety and 
depression. 
 
 
 
 
 
Introduction/background 
 
Despite more than fifty years of research into, and development of, effective behavioural and 
cognitive-behavioural treatments (CBT) for depression and anxiety, the availability of such 
treatments worldwide remains poor (Andrews & Tolkein II Team, 2006; McManus et al, 
2009). Although the evidence in support of CBT as an empirically supported therapy 
(Chambless & Hollon, 1998) is strong, trained therapists are in short supply and the 
organisation of treatments in many countries remains at best ad hoc. Recently, established 
arguments for empirically supported psychological therapy have been strengthened by the 
increased prominence of the evidence based medicine movement in health care generally 
(Sackett et al, 1996). The concept that health care should be based on scientific evidence is 
now mainstream.  
 
In many countries, practice is guided by clinical health care guidance, for example by the 
APA Task Force on Promotion and Dissemination of Psychological Procedures (1995) and 
the UK National Institute of Health and Clinical Excellence (NICE). NICE in particular has 
identified the important role that empirically supported psychological treatments, mainly 
CBT, should have in the treatment of depression (NICE, 2009) and anxiety disorders (NICE, 
2005a; 2005b; 2007). Once guidance is issued, they highlight the inability of health care 
providers to deliver the treatments recommended in the guidelines. For example, in the UK, 
no more than 10% of people with anxiety or depression receive psychological treatments for 
their problems and only 5% of the total disorder prevalence had access to an evidence-based 
psychological treatment (McManus et al, 2009). Worldwide the economic burden of this 
untreated anxiety and depression to economies runs to hundreds of billions of dollars, 
estimated to be £19billion in the UK alone (Layard, 2006).  
 
Although increased investment is one solution to the lack of treatment availability, other 
organisational strategies have been proposed. Foremost amongst these is stepped care (Haaga, 
2000), a system of delivering and monitoring treatments so that the most effective yet least 
resource-intensive treatment is delivered to patients first (Davison, 2000). Stepped care is 
included in Australian and NICE guidelines (Andrews & Tolkein II Team, 2006; NICE, 2007; 
2009) as the method by which treatments for depression and anxiety, including CBT, should 
be delivered. 
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In order to address the severe under-provision of treatments, the UK government has 
instigated a highly ambitious programme of Improving Access to Psychological Therapies 
(IAPT) in England by funding the implementation of NICE guidelines for people suffering 
from depression and anxiety disorders. The IAPT programme aims to address under-provision 
of these treatments by training 3,600 new psychological therapists between 2008-2011 to 
enable 900,000 more people to access treatment, with half of those engaging in treatment 
moving to recovery and 25,000 fewer on sick pay and benefits by 2010/11. 
 
However, the successful implementation of results of randomised clinical trials into routine 
clinical practice is not a foregone conclusion (Bero et al, 1998; Glasgow, Lichtenstein & 
Marcus, 2003; NHS Centre for Reviews and Dissemination, 1999). Treatments developed in 
trials may not translate into situations of contextual heterogeneity (Medical Research Council, 
2008). Add to this factor, the nuances of training and delivery of apparently standardised 
treatments by many hundreds or thousands of individual therapists, and one typically finds far 
greater variation in outcomes than the original trials results (Lambert, Hansen & Harmon, 
2010). Indeed, although Stewart and Chambless (2009) report that for anxiety disorders, data 
from routine practice may closely approximate outcomes seen in trials, they call for more 
observational cohort studies of routine clinical populations, echoing the UK Medical Research 
Council’s (MRC) position that the least well performed element of the research-practice cycle 
is implementation (MRC, 2000; 2008). Long-term surveillance is recommended in the form 
of uncontrolled, longitudinal observational cohort studies to measure the extent to which the 
effects of treatment evidence gathered in RCTs is effectively translated into routine practice. 
 
Therefore, aside from the evidence marshalled by NICE for the effectiveness of psychological 
treatments for depression and anxiety, the IAPT has been underpinned by the results of two 
‘demonstration sites’ which acted as pilot test beds during 2006/7. In one of these sites, 
psychological therapies were delivered using a stepped care organisational protocol (Richards 
& Suckling, 2008) whereby the majority of patients received a low-intensity form of CBT 
such as guided self-help (Gellatly et al, 2007; Hirai & Clum, 2006). This site treated around 
five times more patients than an alternative where many more patients were allocated to 
‘high-intensity’ i.e. standard face to face, CBT (Clarke et al, 2009; Richards & Suckling, 
2009), although the focus in the second site included more patients with those anxiety 
disorders for which there is no good evidence for low-intensity CBT, particularly PTSD. 
Nonetheless, these results showed that the routine implementation of stepped care 
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psychological therapies, primarily CBT, could deliver recovery rates of 55-56%, broadly in 
line with that predicted from RCTs of the constituent psychological treatments. 
 
Although this data (Clarke et al, 2009; Richards & Suckling, 2009) were a significant advance 
on other evaluations of routine psychological therapies practice, which have managed to 
collect data on no more than 33-38% of clinical outcomes for all patients (Stiles et al, 2006; 
2008), it was limited by the cross sectional nature of the study. A significant proportion of our 
patients were still ‘in treatment’ so that in the stepped care site pre-post outcome data were 
only available on 46% of the 2,795 patients who were assessed during the first year of 
operation. At that point it was, therefore, unknown as to how many of the patients still ‘in the 
system’ would complete treatment and meet criteria for recovery after they ceased contact. It 
might be the case that a large proportion of those patients completing contact within the first 
year were more likely to recover, thereby leading to inflated effect sizes. Further, although we 
were able to report effect sizes and recovery rates, we did not analyse the data using reliable 
and clinically significant change criteria (Jacobson & Truax, 1991; McMillan, Gilbody & 
Richards, 2010). These criteria may be a better representation of patient recovery than other 
less sophisticated methods which rely on patients falling below a cut point on a clinical 
outcome measure, no matter what their pre-treatment starting point. Finally, one might also 
argue that the intense scrutiny placed upon the site during the first year of operation might 
question the extent to which our previous data could be said to be ‘routine’. 
 
To remedy these limitations we conducted a prospective study of all patients entering the pilot 
site until the point that they exited the system. Our objective was to determine the clinical 
impact of providing evidence-based psychological treatment in a complete cohort of patients 
with anxiety and depression treated at the site. This remedies the major limitation in our 
previous cross-sectional analysis (Richards and Suckling, 2009) in which a large number of 
patients who had not completed their contacts with the service had unknown outcomes. Our 
prospective method adopts a procedure analogous to an intention to treat analysis in clinical 
trials, but for observational data, where rigorous efforts are made to ensure outcomes for all 
patients are collected. We set a census date three years after the site commenced operations, 
12 months after referral data on all patients in our cohort had been logged at the site, to 
maximise the chances that all patients would have completed contact. We analysed outcome 
data conventionally as well as against the reliable and clinically significant change criteria 
described by Jacobson & Truax (1991), in which the threshold for clinically significant 
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change on any continuous measure of morbidity is set at the point where the probability of 
coming from a clinical and non-clinical distribution is equal, the recommended method of 
quantifying improvement when clinical and non-clinical distributions overlap (McMillan, 
Gilbody & Richards, 2010).. Any patient with a score above this cut point is regarded as 
having a clinically significant level of morbidity. To achieve reliable as well as clinically 
significant change, a patient must improve to below this cut point and improve to a greater 
extent than could be accounted for by the level of test-retest unreliability of the specific 
measure. 
 
Method  
Prospective, longitudinal observational study.  
 
Sample 
The sample consisted of 7,859 consecutive patients referred during 24 months between 1
st
 
July 2006 and 31
st
 August 2008 and completing treatment by 31
st
 August 2009.   
 
Setting  
The study was conducted in a post-industrial city of 290,000 inhabitants in the north of 
England. The population was overwhelmingly white British (97%) and although there are 
areas of affluence, 41% of the population were in the UK nationally defined most deprived 
quintile. Average population mortality from cancer, smoking, heart disease and stroke were 
all significantly above the national UK average. 
 
Interventions 
Clinical care was organised according to stepped care principles. Patients were assessed and 
offered a choice of treatments suitable for their condition. A case manager undertook a face-
to-face assessment, following which patients were offered telephone delivered contacts for 
subsequent appointments, although face-to-face appointments were available. The principle 
adopted was that a low burden/low-intensity treatment should be discussed and offered to 
patients first. Patients were then monitored at each subsequent contact to determine whether 
they required stepping up to a higher intensity of treatment, a decision which was taken after 
assessing patient progress using clinical outcome measures and discussion with the patient 
and the case manager’s supervisor. On very rare occasions high-intensity treatment could be 
offered as a first step where patients specifically requested it and after discussion with the 
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clinician’s supervisor. Low intensity treatment included a CBT-based guided ‘Recovery 
Programme’ (Lovell & Richards, 2008) for depression and a guided self-help manual for 
anxiety (Williams, 2003), both including education about depression and/or anxiety and a 
choice of cognitive and behavioural strategies such as behavioural activation, cognitive 
restructuring, exposure, sleep and panic management and problem solving. Two computerized 
CBT programmes ‘Beating the Blues’ and ‘Fear Fighter’ were also offered to patients. 
Pharmacological treatment remained the responsibility of the patient’s general practitioner at 
all times but patients also received advice on managing their medication if prescribed and if 
they requested it. Workers could also liaise with social care agencies for activities such as 
housing support and debt relief. High-intensity treatment was CBT delivered according to 
Beck’s (1979) manual. 
 
At any one time the service employed 25 low- or high-intensity therapists. During the course 
of the study 51 degree educated and/or experienced mental health workers delivered case 
management. They were specifically trained to deliver high-volume, low-intensity treatments 
via a custom designed 25-day training programme at the University of York – a forerunner of 
the national IAPT low-intensity clinical training curriculum (www.iapt.nhs.uk/). The course 
covered the engagement and assessment of patients with common mental health problems 
together with clinical skills to deliver evidence-based, low-intensity treatments and required 
participants to pass clinical skills competency assessments before seeing patients. Eleven 
mental health professionals with a post-graduate qualification in CBT delivered high-intensity 
CBT.  
 
Measures 
All data was collected by mental health workers as part of their routine clinical practice and 
entered onto a secure electronic management system, ‘PC-MIS’ (www.pc-mis.co.uk) 
designed for managing patient referrals, allocation and progression in the stepped care system 
and for facilitating supervision of low-intensity case managers by more senior workers. 
Clinical measures were recorded at every contact between workers and patients. 
 
Demographic data, collected at intake, included contact details, date of birth, gender, 
ethnicity, referral route, and primary and secondary problems identified by referrers. Workers 
also recorded treatment type given, delivery method (face-to-face or telephone), session 
duration and patient disposition at the end of each contact, including date of treatment ending. 
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Depression: nine-item Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer & Williams, 
2001), range 0-27. The PHQ-9 has been validated in a UK depressed population (Cameron et 
al., 2008; Gilbody et al., 2007), has good psychometric properties – Cronbach’s (1951) alpha 
0.89 (Kroenke, Spitzer & Williams, 2001), with a score of 10 being optimum for identifying 
depressive symptoms likely to be of clinical severity (Gilbody, Richards & Barkham, 2007; 
Kroenke, Spitzer & Williams, 2001).  
 
Anxiety: seven-item General Anxiety Disorder Questionnaire (GAD-7) (Spitzer, Kroenke, 
Williams & Lowe, 2006), range 0-21. The GAD-7 has not been validated in a UK population 
but has good psychometric properties from studies in the US – Cronbach’s (1951) alpha 0.92 
with a score of 8 being optimum for identifying symptoms of general anxiety disorder, panic 
disorder, post-traumatic stress disorder or social anxiety disorder (Kroenke, Spitzer, Williams, 
Monahan & Lowe, 2007). 
 
Data download and cleaning 
Data was downloaded in an anonymised, non-identifiable manner from PC-MIS in the form 
of a series of .csv files which were converted into MSExcel and then analysed with SPSSv14. 
Downloads were obtained in the form of case-by-case datasets and contact-by-contact 
datasets. As this was a routine dataset, with clinical contact data entered by 63 mental health 
workers it required cleaning. Case-by-case data items were examined by GB and cross 
checked by unique patient identifiers against contact-by-contact data and then cleaned of 
inconsistencies, errors and missing data. DR validated all data cleaning. For example, where 
no end of episode date was recorded and no clinical contact had been entered in the last six 
months, the case was coded as ‘closed’ and the last appointment date taken as the end of the 
treatment episode. Further, PC-MIS did not differentiate between episodes of care where 
patients had been discharged and then returned for another treatment episode. We identified 
these cases (n=81) and included data from first episodes only in our analyses. 
 
Statistical analysis 
We divided patients into those referred but not assessed, those receiving one assessment 
contact only and those ‘treated’, i.e. with two or more contacts including the assessment and 
at least one other treatment contact. Workers recorded the final disposition of the treated 
group, using pre-selected values on the electronic patient management system, into those that 
7 
 
jointly agreed with workers to complete treatment, those that dropped out from treatment 
without agreement with workers and those that the workers subsequently found unsuitable 
during treatment (figure 1). We calculated means, standard deviations, frequencies and 
percentages as appropriate for data on patient characteristics and treatment received. We 
calculated pre- and post-treatment change based on several common methods used to define 
treatment outcome: 1) rates of likely depression and anxiety pre- and post-treatment by PHQ-
9 and GAD-7 cut-offs; 2) pre/post effect sizes (initial assessment score minus post-treatment 
score divided by the post-treatment standard deviation – in our case the largest and hence 
most conservative of the pre, pooled or post-treatment standard deviations); 3) relative risks 
(event rate for likely anxiety or depression post-treatment divided by the event rate pre-
treatment); 4) ‘IAPT Recovery Rates’ where recovery = (pre-treatment PHQ-9 > 9 or pre-
treatment GAD-7 > 7) and (post-treatment PHQ-9 < 10 and post-treatment GAD-7 < 8) 
capturing the proportion of patients who were unlikely to be cases of depression and/or 
anxiety post-treatment of those who were likely cases of depression and/or anxiety pre-
treatment; 5) we also calculated reliable and clinically significant change (Jacobson & Truax, 
1991). Clinically significant change is defined as the score at which the probability of coming 
from a clinical and non-clinical distribution is equal. Scores below this point are classified as 
the non-clinical range. Clinically significant change requires that a person is above the cut-off 
pre-treatment (i.e. is in the clinical range) but below it at post-treatment. Reliable change is 
where the change in scores must be greater than that which could be due to the inherent 
unreliability of the measure. We calculated these criteria using estimates from clinical and 
non-clinical population distributions (means and standard deviations) for the PHQ-9 from the 
clinical pre-treatment scores of the current study and the non-clinical distribution and estimate 
of internal reliability from the original PHQ-9 validation study (Kroenke, Spitzer, & 
Williams, 2001). On the basis of these, reliable improvement required an improvement of 6 
points or more and clinically significant change required a person to score 9 or above pre-
treatment and 8 or below post-treatment. The same approach was used to calculate these 
criteria for the GAD-7. Clinical means and standard deviations were taken from the current 
dataset, and non-clinical distribution values and estimates of internal reliability were taken 
from the original validation study of the GAD7 (Spitzer, Kroenke, Williams, & Lowe, 2006). 
For the GAD-7 the corresponding figures were: a pre- to post-treatment improvement of 5 
points or more (reliable improvement) a move from 10 or above pre-treatment to 9 or below 
post-treatment (clinically significant change).  
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In addition, a sensitivity analysis was conducted to test whether recent onset cases were less 
severe and more likely to improve as suggested by Andrews (2001) and Kendler, Walters and 
Kessler (1997). Pre and post scores were calculated separately for patients whose problem 
durations were 0-2, 3-4, 5-6, 7-12, 13-24 and >24 months. 
 
Ethical approval 
This study did not fall under the UK National Patient Safety and National Research Ethics 
Service (NRES) definition of research, (National Patient Safety Agency, 2010) as we did not 
manipulate clinicians’ treatment decisions nor used experimental interventions in this project. 
Therefore, permission to access the routine, anonymised, non-patient identifiable data 
required for this study was granted by the NHS service provider under its data sharing 
agreement, approved by the Trust’ Caldicott Guardian according to national NHS policy.  As 
part of routine clinical practice in the NHS, all patients are informed that their data may be 
used in this manner but that all data will be anonymised and they will not be identified by 
those analysing the data or in any publications arising from it. Data was stripped of all 
sensitive patient identifiers (name, address, post-code, NHS number) before being 
downloaded.  
 
Results  
 
Patient flows: 7859 patients were referred to the service during the census period. Of these, 
5717 (73%) had a recorded assessment in the 12 months following referral. As a percentage 
of these 5717 patients assessed, 1534 (27%) received an assessment and/or advice 
appointment only, with the remaining 4183 (73%) receiving more than one contact. 2949 
(71%) of patients receiving more than one contact completed an agreed programme of 
treatment, 969 (23%) dropped out of such treatment, 262 (6%) were considered no longer 
suitable and three patients died from causes unrelated to their psychological difficulties 
(figure 1). 
 
Insert Figure 1 about here 
 
Demographic data: the mean age of patients referred was 38 years, almost two thirds of 
whom were women (table 1). Three quarters of patients were identified by the referrer as 
depressed with most of the remainder identified as having mixed depression and anxiety or 
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generalised anxiety disorder. Very few patients were identified by referrers as having any of 
the other anxiety disorders. Of the 5717 patients who had a recorded assessment only 52% 
(n=2975) had a recorded date of onset (mean problem duration in months = 32, S.D. 60.95) 
and of the 4183 patients with more than one contact 55% (n=2297) had this data recorded 
(mean problem duration = 31.77, S.D. 58.55).  
 
Insert Table 1 about here 
 
Clinical outcomes: tables 2 and 3 report outcome data for all patients receiving two or more 
contacts with the service. Effect sizes were large for both anxiety and depression, the largest 
effects being seen in those patients completing treatment. At assessment 91% of patients were 
above the cut-of points on either the PHQ-9 or GAD-7 which indicate they meet the criteria 
for a diagnosis, compared to 54% at the last contact. Using reliable and clinically significant 
change criteria, 40% of anxious and 41% of depressed patients were reliably and clinically 
significantly improved with a further 15% of both groups reliably improved, leaving 45% of 
patients scoring above GAD-7 or PHQ-9 criteria as unimproved. Problem duration had no 
effect on pre-treatment scores but a small effect on improvement rates, accounting for a mere 
0.7% of the variance in improvement for both depression (F=2.746, p=0.012) and anxiety 
(F=2.602, p=0.016). Post-hoc analyses (Tukey’s-b) indicated that this effect was caused by 
those patients with chronic problem durations of greater than two years, whose post-treatment 
scores remained higher than the other groups. 
 
 
Insert Table 2 about here 
Insert Table 3 about here 
 
Interventions received: the vast majority of patients who received treatment following an 
assessment did so using written guided self-help for depression (n=3311; 79.2%) and/or 
anxiety (n=2021; 48.3%) or used computerised CBT (n=491; 11.7%). Medication 
management advice was given to 1459 (34.9%) of patients with 1279 (30.6%) receiving 
liaison advice with other services. Eighty one (1.9%) patients were treated with counselling. 
On average patients were treated in relatively few sessions (five) with a short combined 
contact time (three hours), reflecting the essentially low-intensity nature of the stepped care 
system in place (table 4). A total of 275 patients (7% of all patients receiving treatment) 
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received high-intensity CBT, 251 of whom did so after being stepped up from unsuccessful 
low-intensity treatment. These 275 patients comprised 6% (185/3311) of patients who had 
previously received low-intensity depression treatment, 9% (178/2021) low-intensity anxiety 
treatment, 9% (84/919) who had received information only, 8% (109/1459) of patients who 
had received medication advice and 8% (37/491) who had received cCBT (percentages not 
cumulative as patients could receive more  than one low-intensity intervention). Outcomes for 
these patients were then similar to those receiving low -intensity treatments only, with those 
that completed high-intensity treatment doing so in an average of ten hours in a median 
number of sessions of 13 (table 5).  
 
Insert Table 4 about here 
Insert Table 5 about here 
 
Discussion 
We have shown that large scale implementation of evidence-based psychological therapies 
into routine service settings are associated with pre/post effect sizes >1.0 for anxiety and 
depression with reliable or reliable and clinically significant change in 55% of cases. These 
results were achieved by a stepped care system where the majority of cases were treated in 
less than six sessions of contact with mental health workers. This study is unique in that our 
procedures allow us to report an almost complete account of all patients’ outcomes who 
received treatment, the nearest comparable analysis to an intention to treat analysis in a 
clinical trial. This compares to only 62% in our previous cross-sectional analyses (Richards & 
Suckling, 2009) and 33 and 38% in previous reports of routine implementation (Stiles et al, 
2006; 2008).  
 
We can report, therefore, the outcomes of the IAPT demonstration site with far greater 
confidence than previously. Our uncontrolled effect sizes were similar to those observed in 
the more limited cross sectional analyses for depression (1.07 compared to 1.09) and anxiety 
(1.04 compared to 1.07) although this complete longitudinal sample’s post-treatment 
morbidity rates were around 5% more than those seen in the cross sectional sample in both 
depression (41% versus 35%) and anxiety (45% versus 40%). Furthermore, there was no 
evidence that patients with recent onset of symptoms improved more than others, indeed it 
was only patients with very chronic disorders of greater than two years duration that showed 
improvement rates worse than the other duration groups, thus providing no support to the 
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contention that these rates of recovery were unduly associated with greater levels of 
spontaneous remission seen in new onset cases of depression.  
 
Using the ‘IAPT formula’ to calculate recovery (patients who are above case threshold on 
either GAD-7 or PHQ-9 at assessment and who are then below threshold on both measures 
post-treatment) 46% of patients were ‘recovered’. Using more conventional reliable and 
clinically significant change criteria, between 40-41% of patients experienced reliable and 
clinically significant improvement on either depression or anxiety, with a further 15% 
experiencing an improvement that is unlikely to be due to the unreliability of the measure. 
Outcomes for those patients who ended treatment in an agreed and planned manner (2,949 – 
71% of those assessed and receiving two or more contacts) were between 6-9% greater than 
those who dropped out or who were considered no longer suitable for treatment, depending on 
the specific analysis used. 
 
The majority of patients were treated using only low-intensity psychological therapy, 
predominantly low-intensity CBT, in an average of 5.5 sessions (6 sessions for completers) 
taking up to 3.5 hours on average. Telephone contacts occupied more than half of the time 
delivering treatment.  
 
Although remaining a small percentage of the total treated population, the proportion of 
patients receiving high-intensity CBT in this full longitudinal sample was almost three times 
(five times in completers) that of our previous cross sectional analysis, (table 4). Surprisingly, 
almost no patients received CBT without going through an initial low-intensity step – almost 
all high-intensity patients were stepped up from an ineffective course of low-intensity 
treatment. Patients who required a step up to high-intensity CBT treatment needed a median 
of more than three times more high-intensity appointments to achieve comparable treatment 
effect sizes to those receiving low-intensity treatment only (table 5). 
 
Limitations 
Our findings should be interpreted in light of the many limitations of conducting uncontrolled 
implementation studies in routine clinical settings. First and foremost, such uncontrolled 
observational designs cannot ascertain what proportion of the recovery rates could be 
accounted for by factors such as spontaneous remission over time. We tried to investigate the 
potential for higher spontaneous remission rates in those with shorter durations of illness and 
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we found no evidence that patients with very short durations of illness contribute 
disproportionately to the improvement rates reported. However, problem duration data was 
missing for 45% of patients and so conclusions here are tentative. Additionally, it is possible 
that effect sizes for depression may be inflated by the ‘remoralisation’ effect observed in 
patients with anxiety disorders, whose mood may initially lift as a consequence of feeling 
hopeful, even through their specific anxiety symptoms may not have yet ameliorated. 
 
A further significant limitation is the lack of standardised diagnostic interviews. Many 
patients were not even given a ‘probable’ diagnosis by clinical staff (low-intensity staff in 
particular are not trained to formally diagnose patients). Although our self-report measures, 
the PHQ-9 and GAD-7, have good psychometric properties and the cut points we used are 
those reported in validation studies as being the scores with the best balance of diagnostic 
specificity and sensitivity, they do not formally ‘diagnose’. Although it is likely that most of 
our patients would attract a formal diagnosis if interviewed by a diagnostician, we cannot say 
for sure what the exact diagnostic status of our population is. 
 
Another potential bias arises from the collection of measures by staff as part of their everyday 
clinical work, rather than by independent raters. Some protection against observer bias is 
provided by the patient-completed self-report method of data collection but since many 
questionnaires were completed in the presence of workers, the potential for the demands of 
this situation to influence our results remains.  
 
Implications 
Notwithstanding the caveats above, which apply to most uncontrolled clinical implementation 
studies, the results of this observational prospective cohort study have considerable 
implications for the dissemination of evidence-based psychological treatment to routine 
practice. The contribution of our study is enhanced by the fact that clinical outcome measures 
are complete for more than 90% of all patients and final dispositions are known for the total 
population referred, assessed and treated. We know that patients were considerably distressed 
by their symptoms. Despite the lack of formal diagnoses in this service, 91% of patients met 
the PHQ-9 or GAD-7 sensitivity and specificity criteria associated with having a diagnosis. 
Consequently, we can make a number of reasonable assumptions about the extent to which 
low-intensity CBT provided as a part of a stepped care system can be effective. Once patients 
engage in and receive treatment, we could expect between 40-45% of patients treated in such 
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a system to be below the criteria for having a diagnosis on all measures after a short period – 
six sessions over 3.5 hours – of low-intensity CBT delivered predominantly using the 
telephone. More than half of patients treated could demonstrate either clinical and reliable, or 
reliable change. When patients are stepped up to high-intensity treatment, similar proportions 
of patients might recover where low-intensity treatment has failed. However, we are able to 
say less about the performance of high-intensity CBT..The number of high-intensity 
treatments delivered to patients in our sample is low, albeit higher than in our previous study. 
Our dataset does not enable us to determine whether this is due to patient choice, poor 
management of non-response to low-intensity treatment, lack of available high-intensity 
resource – a key factor noted in other observational studies of stepped care (Richards et al, 
2010) – or other unknown clinical or operational factors. 
 
Of those that complete treatment, 40% are likely to show no improvement, some even after a 
trial of high-intensity CBT. High-intensity CBT, interpersonal therapy, brief psychodynamic, 
behavioural couples therapy and counselling approaches are all recommended to some extent 
by NICE in the UK and by other guidelines internationally. The extent to which at least some 
of these 40% would be helped by the provision of more of these high-intensity empirically 
supported treatments cannot be determined by this study. Further research is needed to 
investigate different configurations of low- and high-intensity treatments to identify the 
optimum proportions required to maximise recovery rates. 
 
Although we have demonstrated the feasibility of managing high volumes of patients with 
depression and anxiety through a stepped care system, attrition rates are still higher than we 
would desire. Unlike many studies, we chose to present our data from as near to the beginning 
of the patient pathway as possible, not merely from the point of assessment and allocation to 
treatment within the service. This means that we have no data whatsoever on 2,142 patients 
who did not make it to an assessment following referral from a GP. Curiously, in our study, at 
every point in the patient flow 27% of patients either don’t turn up, don’t come back or drop 
out. Despite waiting a full year after patients had been referred to, and logged by, the service, 
only 4183/7859 (53%) of referred patients received two or more sessions of assessment and 
then treatment. Whilst some patients may have been satisfied with a single advice session, 
many more were lost to the service before and after assessment. This is despite the service 
adopting many of the principle features of collaborative care (Katon et al, 1999; 2010) such as 
telephone case management, designed to improve patient engagement and improve both 
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treatment compliance and outcomes (Gilbody et al, 2006). In routine practice it has previously 
been observed that we are still relatively poor at engaging and retaining our patients (Barrett 
et al, 2008; Gilbert et al, 2005; Wierzbicki & Pekarik, 1993). Disappointingly, even when 
adopting collaborative care procedures, routine services might expect to loose at least a 
quarter of their patients at each stage as they progress through the referral, assessment and 
treatment patient pathway. Systems of quality improvement clearly need further refinement to 
stem the haemorrhage of patients from routine care. 
 
Conclusion 
Recovery rates for patients entering a stepped care service utilising empirically supported 
treatments for anxiety and depression in routine practice are between 40 to 55%, depending 
on specific metric used. However, only half of all patients referred go on to receive treatment. 
Further work is needed to understand and improve engagement and utilisation for patients 
with anxiety and depression in routine services. 
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Table 1.  Patient characteristics 
 
 
One contact only 
(n = 1534) 
 
Two or more contacts 
(n = 4183) 
 
Not assessed 
n=2142 
All referred to services 
(n = 7859) 
 
Age (mean/SD) 
 
 
38.3 (13.7) 
 
39.1 (13.1) 
 
35.2 (13.4) 
 
37.9 (13.4) 
Female/Male (%) 
 
63.5/36.5 66.6/33.4 64.6/35.4 65.4/34.6 
White British (%) 
 
94.0 94.1 90.7 93.1 
GP referral (%) 
 
92.0 93.2 90.8 92.3 
Primary problem identified by referrer  (%/n) 
- Depression 
- Mixed anxiety & depression 
- General anxiety disorder 
- Other anxiety disorders 
- Other disorders1 
- No disorder reported  
 
 
76.0 (1166) 
7.5 (115) 
4.2 (64) 
1.3 (20) 
0.6 (10) 
10.4 (159) 
 
77.2 (3231) 
7.6 (319) 
5.6 (235) 
1.9 (74) 
0.3 (13) 
7.4 (311) 
 
69.7 (1494) 
9.9 (211) 
3.7 (80) 
0.6 (13) 
0.6 (13) 
15.5 (331) 
 
75.0 (5891) 
8.2 (645) 
4.8 (379) 
1.4 (107) 
0.4 (36) 
10.2 (801) 
Secondary problem identified by referrer (%/n) 
- Depression 
- Mixed anxiety & depression 
- Generalised anxiety disorder 
- Other anxiety disorders 
- Other disorders1 
- No disorder reported 
 
 
1.5 (23) 
0.2 (3)  
63.4 (972) 
0.4 (6) 
0.7 (11) 
33.8 (519) 
 
1.8 (74) 
0.1 (6) 
64.5 (2698) 
0.8 (34) 
1.0 (42) 
31.8 (1329) 
 
0.7 (15) 
0.3 (6) 
54.5 (1167) 
0.5 (11) 
1.1 (24) 
42.9 (919) 
 
1.4 (112) 
0.2 (15) 
61.5 (4837) 
0.6 (51) 
1.1 (77) 
35.2 (2767) 
     
 
 1 mental and behavioural disorder due to alcohol, bipolar affective disorder, somatoform disorder, eating disorder, disappearance and death of family member, mental disorders not otherwise specified. 
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Table 2. Improvement and effect size for patients with more than one contact 
 
 
     
     
 Completed treatment 
(n = 2949) 
Dropped out of treatment 
(n = 969) 
Unsuitable for further treatment 
(n = 262) 
Total 
(n = 4183) 
     
Improvement     
     
Pre treatment 
PHQ-9 (mean/SD) 
Median (IQR) 
 
 
15.75 (6.26) 
17 (12-21) 
 
17.1 (5.73) 
18 (13-22) 
 
18.50 (5.57) 
20 (15-23) 
 
16.21 (6.15) 
17 (12-21) 
Post treatment 
PHQ-9 (mean/SD) 
Median (IQR) 
 
7.64 (6.87) 
5 (2-12) 
 
11.73 (6.93) 
11(6-17) 
 
14.97 (7.12) 
16 (9-20) 
 
9.04 (7.27) 
8 (3-14) 
- Effect size (CI) 1.24 (1.01 to 1.48) 0.85 (0.49 to 1.28) 0.56. (-0.12 to 1.42) 1.07 (0.88 to 1.29) 
     
     
     
Pre treatment 
GAD-7 (mean/SD) 
Median (IQR) 
 
13.78 (5.24) 
15 (10-18) 
 
14.57 (4.71) 
15 (12-18) 
 
15.41 (4.63) 
16 (13-19) 
 
14.06 (5.11) 
15 (11-18) 
 
Post treatment 
GAD-7 (mean/SD) 
Median (IQR) 
 
 
6.91(6.07) 
5 (2-11) 
 
 
10.52 (6.14) 
10 (5-16) 
 
 
12.73 (5.79) 
14 (8-17) 
 
 
8.10 (6.37) 
7 (3-13) 
- Effect size (CI) 1.21 (1.03 to 1.43) 0.75 (0.45 to 1.13) 0.51 (-0.05 to 1.22) 1.04 (0.88 to 1.23) 
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Table 3. Relative risk, reliable and clinical change and recovery rates for patients with more than one contact  
 
     
     
 Completed 
treatment 
Dropped out of 
treatment 
Unsuitable for 
further treatment 
Total 
 
     
PHQ-9 (%/n)     
     
- Rate of depression pre treatment 81.7 (2410/2945) 88.4 (857/967) 91.2 (239/262) 83.9 (3508/4177) 
- Rate of depression post treatment 31.9 (941/2906) 58.2 (564/951) 71.4 (187/250) 40.5 (1695/4110) 
- Relative Risk (95% CI) 0.40 (0.37 to 0.41) 0.67 (0.63 to 0.70) 0.82 (0.75 to 0.88) 0.48 (0.47 to 0.51) 
     
- Reliable improvement & clinical significant change 47.3 (1378/2906) 27.1 (237/952)                                                                            16.4 (41/250) 40.8 (1676/4110) 
- Reliable improvement only 13.6 (394/2906) 17.9 (169/952) 14.8 (37/250) 14.6 (600/4110) 
- No improvement 39.0 (1134/2906) 57.0 (539/952) 68.8 (172/250) 44.6 (1834/4110) 
     
GAD-7 (%/n)      
     
- Rate of anxiety pre treatment 84.8 (2502/2945) 90.2 (874/967) 92.4 (242/262) 86.5 (3620/4177) 
- Rate of anxiety post treatment 36.4 (1073/2900) 62.6 (607/944) 74.4 (195/251) 44.9 (1878/4098) 
- Relative Risk (95% CI) 0.44 (0.41 to 0.46) 0.71 (0.68 to 0.75) 0.84 (0.78 to 0.91) 0.53 (0.51 to 0.55) 
     
- Reliable improvement & clinical significant change 47.1 (1367/2900) 25.1 (237/945) 15.9 (40/251) 40.1 (1643/4098) 
- Reliable improvement only 13.8 (399/2900) 17.9 (169/945) 12.4 (31/251) 14.6 (599/4098) 
- No improvement 39.1 (1134/2900) 57.0 (539/945) 71.7 (180/251) 45.3 (1856/4098) 
     
IAPT 1 recovery rate (%/n)     
     
- Case at assessment  89.9 (2647/2949) 94.9 (918/969) 96.2 (252/262) 91.4 (3817/4183) 
- Recovery rate 55.4 (1446/2609) 27.0 (244/904) 15.4 (37/240) 46.0 (1724/3756) 
     
     
 
1 Pre treatment PHQ-9 > 9 or GAD-7 % > 7 and post treatment PHQ-9 < 10 & GAD-7 % < 8 
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Table 4. Description of treatment received by patients with more than one contact  
 
 Total patients 
(n = 4183) 
Completed treatment 
(n = 2949) 
Dropped out of treatment 
(n = 969) 
Unsuitable for further treatment 
(n = 262) 
 
 
Mean time: hours & minutes (SD) 
 
3.15 (3.09) 
 
3.32 (3.27) 
 
2.28 (2.03) 
 
2.49 (2.13) 
Mean numbers of session of contacts (SD) 5.49 (4.31) 6.01 (4.58) 4.15 (3.15) 4.53 (3.61) 
Number of face-to-face contacts (mean/SD) 2.33 (2.96) 2.49 (2.23) 1.90 (2.14) 2.03 (1.33) 
Number of telephone contacts (mean/SD) 3.17 (3.01) 
 
3.53 (3.30) 2.25 (2.21) 2.50 (2.78) 
Patients with at least one1 session of:   (%/n) (%/n) (%/n) 
 
Depression self-help book (n=3311; 79.2% )2 
 
 
 
70.0 (2319) 
 
24.6 (780) 
 
6.3 (209) 
Anxiety self-help book (n=2021; 48.3%)  71.0 (1431) 22.8 (461) 5.8 (118) 
Medication management (n=1459; 34.9%)  70.1 (1017) 26.7 (373) 6.7 (97) 
Liaison (n=1279; 30.6%)  69.0 (883) 20.3 (259) 10.6 (135) 
Information only (n=919; 22.0%)  75.4 (685) 20.0 (181) 5.8 (53) 
Computerized CBT (n=491;11.7%)  76.7 (373) 21.0 (103) 3.1 (15) 
High-intensity CBT (n=275; 6.6%)  79.6(219) 16.4 (45) 4.0 (11)  
Counselling (n=81; 1.9%)  64.2 (52) 24.7 (20) 11.1 (9) 
     
     
 
 
1 Patient could receive more than one treatment 
2 Percentage of all patients receiving any treatment 
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Table 5. The high and low intensity treatment groups (n= 2949)  
 
 Low intensity treatment1 only  
(n=2626) 
High intensity treatment2 
(n=219) 
   
Gender female/male (%) 65.9/34.1 69.4/30.6 
Age (mean/SD) 39.9 (13.15) 38.9 (12.80) 
White British (%) 93.9 94.1 
N treatments (mean/SD) 5.37 (3.44) 13.87 (7.99) 
Median (IQR) 4 (3 – 7) 13 (8 – 19) 
Mean time: hours and minutes (SD) 2.53 (1.54) 10.00 (6.36) 
   
Depression (PHQ-9)   
   
Pre treatment (mean/SD) 15.66 (6.22) 16.85 (6.36) 
Median (IQR) 16.0 (11 – 21) 18.0 (13 – 22) 
   
Post treatment (mean/SD) 7.49 (6.86) 9.25 (6.96) 
Median (IQR) 5.0 (2 - 12) 8.0 (3 - 15) 
- Effect size (CI) 1.25 (1.01 to 1.51) 1.14 (0.3 to 2.06) 
   
Anxiety (GAD-7)   
   
Pre treatment (mean/SD) 13.68 (5.23) 15.12 (5.04) 
Median (IQR) 15.0 (10 - 18) 16.0 (12 – 19) 
   
Post treatment (mean/SD) 6.77 (6.06) 8.49 (6.07) 
Median (IQR) 5.0 (2 - 11) 7.0 (3 - 14) 
- Effect size (CI) 1.22 (1.02 to 1.46) 1.19 (0.53 to 2.00) 
   
   
 
 
 
                                                          
1 Low intensity treatment only = depression self-help book, anxiety self-help book, medication management, signposting, information only, computerized CBT. 
2 High intensity treatment includes patients gone straight to HIT (n = 19) as well as stepped up patients = CBT 
  
 
  
                                             n = 2142 
 
 
 
 
 n = 1534      
  
        
 
 
 
 
 
 
 
 
 
 
 
Figure 1.     Flow diagram of patient pathways & status 
Referrals 1st July 2006 – 31st August 2008
 n = 7859 
Assessment & advice only n = 659 
Declined    n = 198 
Dropped out   n = 437 
Unsuitable for treatment  n = 237 
Deceased   n = 3 
No documented contact  n = 687 
Unsuitable for treatment  n = 237 
Dropped out   n = 764 
Declined  n = 450 
Deceased  n= 4 
   
 
Assessed 
n=5717 
Received more than one contact 
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